Literature DB >> 6156131

Somatic cell hybrids producing antibodies specific to human fibronectin.

L Zardi, B Carnemolla, A Siri, L Santi, R S Accolla.   

Abstract

We have produced somatic cell hybrids between mouse plasocytoma cells deficient in hypoxanthine phosphoribosyltransferase (P3 x 63 Ag8) and spleen cells derived from mice immunized with purified human plasma fibronectin. We report herein the properties of monoclonal anti-fibronectin antibodies released by eight different clones.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6156131     DOI： 10.1002/ijc.2910250304

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


  10 in total

Review 1.  Hybridomas: a new dimension in biological analyses.

Authors:  R H Kennett
Journal:  In Vitro       Date:  1981-12

2.  A comparison of hyaluronan and fibronectin in the healing of tympanic membrane perforations.

Authors:  S Hellström; G D Bloom; L Berghem; L E Stenfors; O Söderberg
Journal:  Eur Arch Otorhinolaryngol       Date:  1991       Impact factor: 2.503

3.  The oncofetal domain of fibronectin defined by monoclonal antibody FDC-6: its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma.

Authors:  H Matsuura; S Hakomori
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

4.  Transformed human cells produce a new fibronectin isoform by preferential alternative splicing of a previously unobserved exon.

Authors:  L Zardi; B Carnemolla; A Siri; T E Petersen; G Paolella; G Sebastio; F E Baralle
Journal:  EMBO J       Date:  1987-08       Impact factor: 11.598

5.  Species-specific monoclonal antibodies in the assignment of the gene for human fibronectin to chromosome 2.

Authors:  L Zardi; M Cianfriglia; E Balza; B Carnemolla; A Siri; C M Croce
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

6.  Transformed human cells release different fibronectin variants than do normal cells.

Authors:  P Castellani; A Siri; C Rosellini; E Infusini; L Borsi; L Zardi
Journal:  J Cell Biol       Date:  1986-11       Impact factor: 10.539

7.  Monoclonal antibodies in the analysis of fibronectin isoforms generated by alternative splicing of mRNA precursors in normal and transformed human cells.

Authors:  L Borsi; B Carnemolla; P Castellani; C Rosellini; D Vecchio; G Allemanni; S E Chang; J Taylor-Papadimitriou; H Pande; L Zardi
Journal:  J Cell Biol       Date:  1987-03       Impact factor: 10.539

8.  Malignant progression of an SV40-transformed human epidermal keratinocyte cell line.

Authors:  K W Brown; P H Gallimore
Journal:  Br J Cancer       Date:  1987-11       Impact factor: 7.640

9.  Distribution of laminin and fibronectin isoforms in oral mucosa and oral squamous cell carcinoma.

Authors:  H Kosmehl; A Berndt; S Strassburger; L Borsi; P Rousselle; U Mandel; P Hyckel; L Zardi; D Katenkamp
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

10.  A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors.

Authors:  B Carnemolla; E Balza; A Siri; L Zardi; M R Nicotra; A Bigotti; P G Natali
Journal:  J Cell Biol       Date:  1989-03       Impact factor: 10.539
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.